CFG
IMNM icon

Citizens Financial Group’s Immunome IMNM Stock Holding History

Citizens Financial Group’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$436K Sell
19,954
-46
-0.2% -$1.02K 0.01% 574
2025
Q4 		$430K Hold
20,000
– – 0.01% 579
2025
Q3 		$234K Hold
20,000
– – ﹤0.01% 723
2025
Q2 		$186K Hold
20,000
– – ﹤0.01% 670
2025
Q1 		$135K Buy
+20,000
New +$192K ﹤0.01% 602

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return

Citizens Financial Group's IMNM Position: Q1 2026 in Review

Citizens Financial Group reduced its Immunome (IMNM) stake by 0.23% in Q1 2026, selling an estimated $1.02K and leaving 19,954 shares worth $436K. The position accounts for 0.01% of the portfolio, ranked #574.

Citizens Financial Group first reported a position in IMNM in Q1 2025 and has held it in 5 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • Citizens Financial Group held 19,954 shares of Immunome worth $436K as of Q1 2026.
  • Citizens Financial Group sold 46 Immunome shares in Q1 2026, an estimated $1.02K.
  • Immunome made up 0.01% of Citizens Financial Group's portfolio in Q1 2026, its #574 holding.
  • Citizens Financial Group first reported a position in Immunome in Q1 2025 and has held it in 5 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on Citizens Financial Group's 13F filing for Q1 2026, filed 1 May 2026.